l’Université fédérale de Minas Gerais (UFMG)

It will be tested on volunteers without a history of infection. The Brazilian Medicines Agency, Anvisa, has authorized the launch of human clinical trials of the world’s first malaria vaccine caused by Plasmodium vivax , the parasite responsible for most malaria cases in Brazil. This vaccine is produced with 100% Brazilian technology. In a press…